此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Dexmedetomidine as an Adjuvant to Bupivacaine in Fascia Iliaca Block for Femoral Fracture Surgery Under General Anesthesia: A Dose-Finding Study (FIB-DEX)

2026年11月17日 更新者:Alaa mahmoud bahaa eldin mohamed taha、Cairo University

Dexmedetomidine Added to Bupivacaine in Fascia Iliaca Block Combined With General Anesthesia for Femoral Fracture Surgery: A Dose-Finding Randomized Double-Blind Study

### Brief Summary

Femoral fractures can cause severe pain during and after surgery. Although fascia iliaca block is commonly used to relieve pain in patients undergoing femoral fracture surgery, the duration of pain relief may be limited.

Dexmedetomidine is a medication that may prolong the pain-relieving effect of local anesthetics such as bupivacaine. However, the most appropriate dose of dexmedetomidine for this type of nerve block is not yet clearly established.

This study aims to determine the lowest effective dose of dexmedetomidine when added to bupivacaine for ultrasound-guided fascia iliaca block in patients undergoing femoral fracture surgery under general anesthesia.

The study includes 90 adult patients, aged 18-75 years, who are scheduled for femoral fracture surgery. Participants will be randomly assigned to one of three groups, with 30 patients in each group. All patients will receive general anesthesia and an ultrasound-guided fascia iliaca block containing 30 mL of 0.25% bupivacaine, combined with one of the following doses of dexmedetomidine:

  • Group A: 0.5 micrograms/kg.
  • Group B: 0.75 micrograms/kg.
  • Group C: 1 microgram/kg.

Neither the patients nor the doctors assessing the study outcomes will know which dose has been administered.

Pain levels will be assessed during the first 24 hours after surgery using a numerical pain scale. The study will also measure the time until patients first require additional pain medication and the total amount of pain medication used.

Other assessments will include leg muscle strength, level of sedation, heart rate, blood pressure, and any possible side effects or complications.

The main purpose of this study is to identify the lowest dose of dexmedetomidine that provides effective postoperative pain relief while minimizing unwanted effects, helping improve pain management and recovery after femoral fracture surgery.

研究概览

地位

尚未招聘

条件

干预/治疗

研究类型

介入性

注册 (估计的)

90

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

Age between 18-75 years. both sexes. American Society of Anesthesiologists (ASA) physical status I-III Scheduled for femoral fracture surgery

Exclusion Criteria:

Allergy to study drugs. Heart block type II. Pre-existing neurologic or psychiatric disease. Severe hepatic or renal impairment. Infection at injection site.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:四人间

武器和干预

参与者组/臂
干预/治疗
有源比较器:dexmedetomidine 0.5

Name: Dexmedetomidine 0.5 µg/kg with bupivacaine for supra-inguinal fascia iliaca block

Description: Ultrasound-guided supra-inguinal fascia iliaca compartment block using 30 mL of 0.25% bupivacaine combined with dexmedetomidine 0.5 µg/kg, administered perineurally. The block is used as part of the perioperative analgesic regimen in patients undergoing femoral fracture surgery under general anesthesia

Intervention 1 - Group dexmeditomidine 0.5

Dexmedetomidine 0.5 µg/kg with bupivacaine for supra-inguinal fascia iliaca block

Description: Ultrasound-guided supra-inguinal fascia iliaca compartment block using 30 mL of 0.25% bupivacaine combined with dexmedetomidine 0.5 µg/kg, administered perineurally. The block is used as part of the perioperative analgesic regimen in patients undergoing femoral fracture surgery under general anesthesia.

---

其他名称:
  • 布比卡因
有源比较器:dexmedetomidine 0.75

Name: Dexmedetomidine 0.75 µg/kg with bupivacaine for supra-inguinal fascia iliaca block

Description: Ultrasound-guided supra-inguinal fascia iliaca compartment block using 30 mL of 0.25% bupivacaine combined with dexmedetomidine 0.75 µg/kg, administered perineurally. The block is used as part of the perioperative analgesic regimen in patients undergoing femoral fracture surgery under general anesthesia.

Name: Dexmedetomidine 0.75 µg/kg with bupivacaine for supra-inguinal fascia iliaca block

Description: Ultrasound-guided supra-inguinal fascia iliaca compartment block using 30 mL of 0.25% bupivacaine combined with dexmedetomidine 0.75 µg/kg, administered perineurally. The block is used as part of the perioperative analgesic regimen in patients undergoing femoral fracture surgery under general anesthesia.

有源比较器:dexmedetomidine 1

Name: Dexmedetomidine 1 µg/kg with bupivacaine for supra-inguinal fascia iliaca block

Description: Ultrasound-guided supra-inguinal fascia iliaca compartment block using 30 mL of 0.25% bupivacaine combined with dexmedetomidine 1 µg/kg, administered perineurally. The block is used as part of the perioperative analgesic regimen in patients undergoing femoral fracture surgery under general anesthesi

Name: Dexmedetomidine 1 µg/kg with bupivacaine for supra-inguinal fascia iliaca block

Description: Ultrasound-guided supra-inguinal fascia iliaca compartment block using 30 mL of 0.25% bupivacaine combined with dexmedetomidine 1 µg/kg, administered perineurally. The block is used as part of the perioperative analgesic regimen in patients undergoing femoral fracture surgery under general anesthesia.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Time to the first request for rescue analgesia in minutes
大体时间:from end of surgery to the first request for nalbuphine

time in minutes to first rescue analgesia will be measured.

from end of surgery to the first request for nalbuphine

次要结果测量

结果测量
措施说明
大体时间
postoperative pain assessed as Numerical rating score (NRS)
大体时间:from 30 minutes after surgery to 24 hours after surgery
from 30 minutes after surgery to 24 hours after surgery
motor block using modified bromage scale
大体时间:from 30 minutes to 24 hours after surgery
from 30 minutes to 24 hours after surgery
total nalbuphine consumption in milligram (mg)
大体时间:from end of surgery to 24 hours after surgery
from end of surgery to 24 hours after surgery
heart rate
大体时间:starting before general anesthesia till 60 minutes after surgery
starting before general anesthesia till 60 minutes after surgery
sedation score
大体时间:from 30 minutes after the end of operations to 24 hours postoperative .

using ramsay sedation scale

from 30 minutes after the end of operations to 24 hours postoperative .
mean arterial pressure
大体时间:starting before general anesthesia till 60 minutes after surgery
starting before general anesthesia till 60 minutes after surgery
systolic blood pressure
大体时间:starting before general anesthesia till 60 minutes after surgery
starting before general anesthesia till 60 minutes after surgery
diastolic blood pressure
大体时间:starting before general anesthesia till 60 minutes after surgery
starting before general anesthesia till 60 minutes after surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年12月15日

初级完成 (估计的)

2027年3月1日

研究完成 (估计的)

2027年4月1日

研究注册日期

首次提交

2026年11月11日

首先提交符合 QC 标准的

2026年11月17日

首次发布 (实际的)

2026年11月19日

研究记录更新

最后更新发布 (实际的)

2026年11月19日

上次提交的符合 QC 标准的更新

2026年11月17日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • MS-228-2026

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.